- Archer-Daniels-Midland Co (NYSE:ADM) has revealed equity investment in Acies Bio, a Slovenia-based biotechnology company. The company did not disclose specific financial details of the investment.
- Acies Bio specializes in R&D and manufacturing services for developing and scaling synthetic biology and precision fermentation technologies for food, agriculture, and industrial applications.
- ADM expects the investment to help more quickly advance projects in the field of precision microbial fermentation.
- ADM is investing in Acies Bio through its corporate venture capital arm, ADM Ventures.
- Price Action: ADM shares are trading higher by 1.03% at $65.64 on the last check Friday.
UBS Maintains Neutral on First Republic Bank, Lowers Price Target to $188
UBS analyst Erika Najarian maintains First Republic Bank (NYSE:FRC) with a Neutral and lowers the price target from $210 to $188.
